NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Jong Hyeon Jeong
University of Pittsburgh - Pittsburgh / United States
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 1778916
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Jong Hyeon Jeong's MOST POPULAR ARTICLES
1-)
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancerB Fisher, S Anderson, J Bryant, RG Margolese, M Deutsch, ER Fisher, ...New England Journal of Medicine 347 (16), 1233-1241, 200271712002
2-)
Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiationB Fisher, JH Jeong, S Anderson, J Bryant, ER Fisher, N WolmarkNew England Journal of Medicine 347 (8), 567-575, 200216082002
3-)
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2–positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG …EA Perez, EH Romond, VJ Suman, JH Jeong, G Sledge, CE Geyer Jr, ...Journal of clinical oncology 32 (33), 3744, 20149052014
4-)
Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2–positive breast cancer: joint analysis of data from NCCTG …EA Perez, EH Romond, VJ Suman, JH Jeong, NE Davidson, CE Geyer Jr, ...Journal of clinical oncology 29 (25), 3366-3373, 20119622011
5-)
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus …EH Romond, JH Jeong, P Rastogi, SM Swain, CE Geyer Jr, MS Ewer, ...Journal of Clinical Oncology 30 (31), 3792-3799, 20125952012
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept